CN106399244A - 一种nk细胞培养基 - Google Patents
一种nk细胞培养基 Download PDFInfo
- Publication number
- CN106399244A CN106399244A CN201610961055.8A CN201610961055A CN106399244A CN 106399244 A CN106399244 A CN 106399244A CN 201610961055 A CN201610961055 A CN 201610961055A CN 106399244 A CN106399244 A CN 106399244A
- Authority
- CN
- China
- Prior art keywords
- cell
- culture medium
- present
- cell medium
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000822 natural killer cell Anatomy 0.000 title claims abstract description 70
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 10
- 229920001184 polypeptide Polymers 0.000 claims abstract description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 8
- 239000001963 growth medium Substances 0.000 claims description 32
- 239000006143 cell culture medium Substances 0.000 claims description 24
- 239000007640 basal medium Substances 0.000 claims description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 2
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000002147 killing effect Effects 0.000 abstract description 13
- 210000004881 tumor cell Anatomy 0.000 abstract description 12
- 241000190633 Cordyceps Species 0.000 abstract description 5
- 150000004676 glycans Chemical class 0.000 abstract description 5
- 239000005017 polysaccharide Substances 0.000 abstract description 5
- 102000000588 Interleukin-2 Human genes 0.000 abstract description 4
- 108010002350 Interleukin-2 Proteins 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000003102 growth factor Substances 0.000 abstract description 2
- 229940125396 insulin Drugs 0.000 abstract description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 238000006062 fragmentation reaction Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 2
- YXVAESUIQFDBHN-SRVKXCTJSA-N Asn-Phe-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O YXVAESUIQFDBHN-SRVKXCTJSA-N 0.000 description 2
- YRBGRUOSJROZEI-NHCYSSNCSA-N Asp-His-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O YRBGRUOSJROZEI-NHCYSSNCSA-N 0.000 description 2
- KIHRUISMQZVCNO-ZLUOBGJFSA-N Cys-Asp-Asp Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KIHRUISMQZVCNO-ZLUOBGJFSA-N 0.000 description 2
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 2
- ABLQPNMKLMFDQU-BIIVOSGPSA-N Cys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CS)N)C(=O)O ABLQPNMKLMFDQU-BIIVOSGPSA-N 0.000 description 2
- YNJBLTDKTMKEET-ZLUOBGJFSA-N Cys-Ser-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O YNJBLTDKTMKEET-ZLUOBGJFSA-N 0.000 description 2
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- AYPMIIKUMNADSU-IHRRRGAJSA-N Phe-Arg-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O AYPMIIKUMNADSU-IHRRRGAJSA-N 0.000 description 2
- QHSSPPHOHJSTML-HOCLYGCPSA-N Val-Trp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N QHSSPPHOHJSTML-HOCLYGCPSA-N 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 229920001231 Polysaccharide peptide Polymers 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 108010022457 polysaccharide peptide Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610961055.8A CN106399244B (zh) | 2016-10-28 | 2016-10-28 | 一种nk细胞培养基 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610961055.8A CN106399244B (zh) | 2016-10-28 | 2016-10-28 | 一种nk细胞培养基 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106399244A true CN106399244A (zh) | 2017-02-15 |
CN106399244B CN106399244B (zh) | 2020-02-21 |
Family
ID=58013733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610961055.8A Active CN106399244B (zh) | 2016-10-28 | 2016-10-28 | 一种nk细胞培养基 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106399244B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418931A (zh) * | 2017-08-17 | 2017-12-01 | 重庆斯德姆生物技术有限公司 | 一种提高活率的细胞培养液 |
CN109234161A (zh) * | 2018-09-25 | 2019-01-18 | 深圳市宝迪生物工程有限公司 | 一种干细胞培养液用的震荡装置及其使用方法 |
CN111620932A (zh) * | 2020-06-30 | 2020-09-04 | 南京赛尔健生物技术有限公司 | 一种多肽及在促进nk细胞增殖和提高其对肿瘤细胞杀伤力方面的应用 |
CN111718399A (zh) * | 2020-06-30 | 2020-09-29 | 南京赛尔健生物技术有限公司 | 一种多肽及用于nk细胞培养、制备nk细胞培养基的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894065A (zh) * | 2015-07-09 | 2015-09-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种nk细胞培养基及nk细胞的培养方法 |
-
2016
- 2016-10-28 CN CN201610961055.8A patent/CN106399244B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894065A (zh) * | 2015-07-09 | 2015-09-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种nk细胞培养基及nk细胞的培养方法 |
Non-Patent Citations (5)
Title |
---|
D. TOLKATCHEV等: "A peptide derived from the C-terminal part of a plant cysteine protease folds into a stack of two b-hairpins, a scaffold present in the emerging family of granulin-like growth factors", 《J. PEPT. RES.》 * |
D. TOLKATCHEV等: "Chain A, The Solution Structure Of A 35-Residue Fragment From The GranulinEPITHELIN-Like Subdomain Of Rice Oryzain Beta (Rob 382-416 (C398s,C399s,C407s,C413s)),PDB: 1FWO_A,35aa linea", 《NCBI GENBANK》 * |
朱铁英等: "蛹虫草菌粉对肝硬化患者T细胞免疫调节作用的研究", 《中国医药指南》 * |
贡成良等: "家蚕蛹虫草对小鼠免疫调节的影响", 《蚕业科学》 * |
郭随章: "中药多糖的抗癌研究与临床应用进展", 《医药导报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418931A (zh) * | 2017-08-17 | 2017-12-01 | 重庆斯德姆生物技术有限公司 | 一种提高活率的细胞培养液 |
CN109234161A (zh) * | 2018-09-25 | 2019-01-18 | 深圳市宝迪生物工程有限公司 | 一种干细胞培养液用的震荡装置及其使用方法 |
CN111620932A (zh) * | 2020-06-30 | 2020-09-04 | 南京赛尔健生物技术有限公司 | 一种多肽及在促进nk细胞增殖和提高其对肿瘤细胞杀伤力方面的应用 |
CN111718399A (zh) * | 2020-06-30 | 2020-09-29 | 南京赛尔健生物技术有限公司 | 一种多肽及用于nk细胞培养、制备nk细胞培养基的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN106399244B (zh) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230399615A1 (en) | Icos critically regulates the expansion and function of inflammatory human th17 cells | |
CN106399244A (zh) | 一种nk细胞培养基 | |
CN102618498B (zh) | Hla-a0201限制性抗原特异性ctl制备方法 | |
CN107922925A (zh) | 用于自然杀伤细胞扩增的方法 | |
CN109182266A (zh) | 扩大t细胞的方法 | |
CN105567634A (zh) | 一种用于nk细胞体外扩增的培养基及nk细胞体外扩增的方法 | |
CN100591760C (zh) | 制备细胞毒性淋巴细胞的方法 | |
CN102216446A (zh) | 制备t细胞的体系和方法 | |
CN106581668B (zh) | 一种抗原表位肽组合物及其应用 | |
KR20210111747A (ko) | 세포를 단리 및 증식하는 방법 | |
EP1666589B1 (en) | Process for producing cytotoxic lymphocytes | |
CN115558641B (zh) | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 | |
Zandstra et al. | Cellular determinants affecting the rate of cytokine in cultures of human hematopoietic cells | |
CN106604989A (zh) | 用于制备树突状细胞的方法、由该方法制备的树突状细胞、及其应用 | |
CN104073467A (zh) | 一种人dccik免疫活性细胞的制备方法 | |
CN102719400B (zh) | Hla-a0201限制性抗cea抗原特异性ctl的制备方法 | |
Sun et al. | Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo | |
CN114250198A (zh) | 一种增强免疫细胞抗肿瘤效果的方法 | |
CN108707579A (zh) | 一种人t淋巴细胞培养用的无血清培养基及制备方法和培养方法 | |
CN107502592A (zh) | 一种免疫细胞无血清培养基及其制备方法 | |
CN105018423A (zh) | Cik细胞培养方法 | |
CN109486828A (zh) | 一种编码重组人白细胞介素12的基因及其应用 | |
CN116179596A (zh) | 长效化重组人白细胞介素2融合蛋白及其制备方法和应用 | |
CN106190975A (zh) | 黑色素瘤抗原特异性ctl及其制备方法 | |
CN106119192B (zh) | 组合物及其在cik细胞培养中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240511 Address after: Building B505, Yinxing Zhijie Phase II, No. 1301-76, Guanlan Community, Guanlan Street, Longhua District, Shenzhen City, Guangdong Province, 518110 Patentee after: SHENZHEN BAODI BIOLOGICAL ENGINEERING Co.,Ltd. Country or region after: China Address before: Room 504, Administrative and Business District, Binhai Park, Nantong City, Jiangsu Province, 226399 Patentee before: NANTONG BAOTONGKANG BIOLOGY ENGINEERING STOCK Co.,Ltd. Country or region before: China |